What technical signals does GT Biopharma (GTBP) have?

GT Biopharma current technical signals: no active technical signal.

Is GT Biopharma a cup-and-handle pattern?

No. GT Biopharma has no valid Cup signal right now.

What published figures are available for GT Biopharma?

Market cap: $57.54M. Trailing 12 months PER: -0.4×. Latest quarter PBR: 2.35×. Dividend yield: 0.00%.

← Signal Board

GT Biopharma stock price

NASDAQ:GTBP · Nasdaq · Healthcare · sector #16

$5.41-25.99%Oct 21 close

Ask Q Order

GT Biopharma's chart data is dated 2026-10-21. There is no active technical signal. The display ticker is GTBP.

GT Biopharma last closed at $5.41 (-25.99%) on 2026-10-21. Listed on Nasdaq. Trailing 12 months PER is -0.4×. Its overall grade ranks 663 of 727 stocks in Healthcare.

About this company

GT Biopharma last closed at $5.41 (-25.99%) on 2026-10-21. Listed on Nasdaq.

Details →

Reported results

Details →

Position in sector

Healthcare · Overall F · 663/727

Valuation grade C

Details →

Related stocks

Sorrento TherapeuticsCompetitor
Innate PharmaCompetitor
AffimedCompetitor

Details →

About GT Biopharma

What technical signals does GT Biopharma (GTBP) have?: GT Biopharma current technical signals: no active technical signal.
Is GT Biopharma a cup-and-handle pattern?: No. GT Biopharma has no valid Cup signal right now.
What published figures are available for GT Biopharma?: Market cap: $57.54M. Trailing 12 months PER: -0.4×. Latest quarter PBR: 2.35×. Dividend yield: 0.00%.

Like these rules? Backtest them.

Run this signal on this ticker in the free backtest builder — same window, no install.

Backtest this rule ↗

Turn what you saw on this name into a strategy

Ask Q about GT Biopharma, or open the plan table on the main site.

Ask Q about GT Biopharma.

Ask Q ↗See plans ↗Strategy library ↗

From the names you found to a trading rule

Tell Q about the stocks you found to place orders with your conditions.

See plans ↗

Quantus Signal · live data · not investment advice · Privacy Policy